Keywords: havrix, gains, chinese, approval, smithkline, beecham, gained

Havrix Gains Chinese Approval

Article | 20 March 1995

Print This

SmithKline Beecham has gained registration approval in China for its hepatitis A vaccine Havrix. The vaccine is now registered in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in